探究茶黄素（TF1）对人肝癌Bel-7402细胞的影响,并阐明其作用机制。通过CCK-8检测细胞活力,用平板克隆形成试验检测细胞增殖能力,细胞划痕愈合试验和Transwell小室法检测细胞迁移,用流式细胞术检测细胞凋亡,Western blot检测细胞凋亡相关蛋白（Bax、Bcl-2、PARP）、迁移相关蛋白（E-cad、N-cad、Vimentin、MMP9）和信号通路相关蛋白（TGF-β、smad3、p-smad3）表达水平。结果表明,不同剂量TF1均可抑制Bel-7402细胞的增殖和迁移,促进其凋亡,并且存在剂量依赖性,剂量越大,抑制作用越强（P<0.05）。与对照组相比,试验组Bax、E-cad蛋白表达水平较高,Bcl-2、PARP,N-cad、Vimentin、MMP9、TGF-β、smad3、p-smad3表达水平较低（P<0.05）。茶黄素可能通过TGF-β信号通路抑制肝癌Bel-7402细胞的增殖、迁移,且促进其凋亡。
To explore the inhibitory effect and mechanism of theaflavin (TF1), human hepatoma carcinoma Bel-7402 cells were treated with different concentrations of TF1. Cell viability was detected by CCK8 and cell proliferation was detected by colony formation assay. Cell migration was detected by cell wound healing experiment and transwell chamber assay. Cell apoptosis was detected by flow cytometry. Apoptosis-related proteins (Bax, Bcl-2, PARP), migration related proteins (E-cad, N-cad, Vimentin, MMP9) and signaling pathway related proteins (TGF-β, Smad3, p-smad3) were detected by western blot. The results show that different concentrations of TF1 could inhibit the proliferation and migration of Bel-7402 cells and promote their apoptosis in a dose-dependent manner. The higher the dose, the stronger the inhibition effect (P<0.05). Compared with the control group, the expression levels of Bax and E-cad proteins in the experimental group were higher, while the expression levels of Bcl-2, PARP, N-cad, Vimentin, MMP9, TGF-β, Smad3 and p-smad3 were lower (P<0.05). In conclusion, TF1 could inhibit the proliferation and migration of Bel-7402 cells and promote their apoptosis through TGF-β signaling pathway.
[1] Zhang Z, Wang M, Xing S, et al.Flavonoids of Rosa rugosa Thunb. inhibit tumor proliferation and metastasis in human hepatocellular carcinoma HepG2 cells[J]. Food Science and Human Wellness, 2022, 11(2): 374-382.
[2] Yang J D, Hainaut P, Gores G J, et al.A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16(10): 589-604.
[3] Chen W Q, Zheng R S, Baade P D, et al.Cancer statistics in China, 2015[J]. CA: A Cancer Journal for Clinicians, 2016, 66(2): 115-132.
[4] Girardi D M, Pacífico J P M, Amorim F, et al. Immunotherapy and targeted therapy for hepatocellular carcinoma: a literature review and treatment perspectives[J]. Pharmaceuticals, 2020, 14(1): 28. doi: 10.3390/ph14010028.
[5] Himangshu S, Kirtikar S, Sumedha K, et al.Vialinin A, an edible mushroom-derived p-terphenyl antioxidant, prevents VEGF-induced neovascularization in vitro and in vivo[J]. Oxidative Medicine and Cellular Longevity, 2018: 1052102. doi: 10.1155/2018/1052102.
[6] Roberts E.The phenolic substances of manufactured tea. X.—the creaming down of tea liquors[J]. Journal of the Science of Food and Agriculture, 2010, 14(10): 700-705.
[7] He H F.Research progress on theaflavins: efficacy, formation, and preparation[J]. Food & Nutrition Research, 2017, 61(1): 1344521. doi: 10.1080/16546628.2017.1344521.
[8] Lakshmishri L, Baisakhi S, Juni C, et al.Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells[J]. Carcinogenesis, 2010, 31(2): 259-268.
[9] Sun S L, Pan S S, Miao A Q, et al.Active extracts of black tea (Camellia sinensis) induce apoptosis of PC-3 prostate cancer cells via mitochondrial dysfunction[J]. Oncology Reports, 2013, 30(2): 763-772.
[10] Shi S, Ma B, Sun F, et al.Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability[J]. Journal of Biological Chemistry, 2021: 101016. doi: 10.1016/j.jbc.2021.101016.
[11] Imran A, Butt M S, Xiao H, et al.Inhibitory effect of black tea (Camellia sinensis) theaflavins and thearubigins against HCT 116 colon cancer cells and HT 460 lung cancer cells[J]. Journal of Food Biochemistry, 2019, 43(5): e12822. doi: 10.1111/jfbc.12822.
[12] Gao Y, Yin J F, Tu Y Y, et al.Theaflavin-3,3'-digallate suppresses human ovarian carcinoma OVCAR-3 cells by regulating the checkpoint kinase 2 and p27 kip1 pathways[J]. Molecules, 2019, 24(4): 673. doi: 10.3390/molecules24040673.
[13] Singh M, Singh R, Bhui K, et al.Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells[J]. Oncology Research Featuring Preclinical & Clinical Cancer Therapeutics, 2011, 19(6): 245-257.
[14] 屠幼英, 谢先吉. 茶黄素单体对三种癌细胞生长抑制研究[C]//浙江省科学技术协会. 浙江省生物化学与分子生物学学术交流会论文集. [出版地不详]: [出版者不详], 2005: 153-160.
Tu Y Y, Xie X J.Growth inhibition of three cancer cells by theaflavin monomer[C]//Zhejiang Association for Science and Technology. Proceedings of the Zhejiang Provincial Biochemistry and Molecular Biology Academic Exchange Conference. [s.n.]: [s.n.], 2005: 153-160.
[15] Air pollution and lung cancer incidencein 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)[J]. Lancet Oncology, 2013, 14(9): 813-822.
[16] Gupta P, Srivastava S K.Inhibition of HER2-integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression[J]. Oncotarget, 2014, 5(7): 1812-1828.
[17] 孙俊, 徐伟, 陆荣柱, 等. 姜黄素对人肝癌SMMC-7721细胞裸鼠移植瘤的抑制作用及其机制[J]. 江苏大学学报(医学版), 2022, 32(3): 219-225, 230.
Sun J, Xu W, Lu R Z, et al.The inhibitory effect and mechanism of curcumin on human SMMC-7721 cells naked rat graft tumor[J]. Journal of Jiangsu University (Medical edition), 2022, 32(3): 219-225, 230.
[18] 方斌. 吉马酮抑制肝癌HepG2细胞增殖机制研究[D]. 武汉: 华中科技大学, 2013.
Fang B.Mechanism of gemarone inhibiting HepG2 cell proliferation in HCC [D]. Wuhan: Huazhong University of Science and Technology, 2013.
[19] 邓鹏裔. 芝麻素对人肝癌细胞系HepG2的抑制作用及机理研究[D]. 武汉: 华中科技大学, 2013.
Deng P Y.Inhibition effect and mechanism study of sesamin on HepG2 in the human HCC cell line [D]. Wuhan: Huazhong University of Science and Technology, 2013.
[20] 张超, 赵海建, 周伟燕, 等. 淫羊藿素调控miRNA-329和miRNA-1236抑制肝癌细胞增殖的机制研究[J]. 肿瘤研究与临床, 2021, 33(11): 805-810.
Zhang C, Zhao H J, Zhou W Y, et al.The mechanism of regulating miRNA-329 and miRNA-1236 regulation in inhibiting HCC cell proliferation[J]. Oncology Research and Clinical, 2021, 33(11): 805-810.
[21] 刘尊东, 魏恒云, 杨亚宗, 等. 褐藻多糖硫酸酯对肿瘤HepG2细胞EMT的影响[C]//中国药学会. 第十二届海洋药物学术年会会刊. [出版地不详]: [出版者不详], 2015: 97.
Liu Z D, Wei H Y, Yang Y Z, et al.Effect of brown algae polysaccharide sulfate on EMT in tumor HepG2 cells [C]//Chinese Pharmaceutical Association. The 12th Annual Marine Medicine Academic Conference. [s.n.]: [s.n.], 2015: 97.
[22] W Y H, Kuraji R, Taya Y, et al. Effects of theaflavins on tissue inflammation and bone resorption on experimental periodontitis in rats[J]. Journal of Periodontal Research, 2018, 53(6): 1009-1019.
[23] Tanaka Y, Kirita M, Miyata S, et al.O-Methylated theaflavins suppress the intracellular a ccumulation of triglycerides from terminally differentiated human visceral adipocytes[J]. Journal of Agricultural & Food Chemistry, 2013, 61(51): 12634-12639.
[24] Fatima M, Kesharwani R K, Misra K, et al.Protective effect of theaflavin on erythrocytes subjected to in vitro oxidative stress[J]. Biochemistry Research International, 2013, 2013: 649759. doi: 10.1155/2013/649759.
[25] Tan Q Y, Peng L J, Huang Y Y, et al.Structure-activity relationship analysis on antioxidant and anticancer actions of theaflavins on human colon cancer cells[J]. Journal of Agricultural and Food Chemistry, 2018, 67(1): 159-170.
[26] 左灵妮, 刘康, 马晓勤, 等. 茶黄素通过调控miR-190表达对LPS诱导的结肠上皮细胞炎症损伤的影响[J]. 中国免疫学杂志, 2021, 37(17): 2087-2092.
Zuo L N, Liu K, Ma X Q, et al.Effect of theaflavin on LPS-induced inflammatory damage in colon epithelial cells by regulating miR-190 expression[J]. Chinese Journal of Immunology, 2021, 37(17): 2087-2092.
[27] 曹亮. 胃肠癌非编码RNA调控TGF-β信号通路新机制研究[D]. 郑州: 郑州大学, 2019.
Cao L.New mechanism of TGF-β signaling pathway regulation by noncoding RNA in gastrointestinal cancer [D]. Zhengzhou: Zhengzhou University, 2019.
[28] 钟永泷. KIF18A在肺腺癌中的生物学功能及作用机制研究[D]. 南宁: 广西大学, 2020.
Zhong Y L.Biological function and action mechanism of KIF18A in lung adenocarcinoma [D]. Nanning: Guangxi University, 2020.
[29] Yamashita K, Sakuramoto S, Kikuchi S, et al.Laparoscopic versus open distal gastrectomy for early gastric cancer in Japan: long-term clinical outcomes of a randomized clinical trial[J]. Surgery Today, 2016, 46(6): 741-749.
[30] Suzuki H, Oda I, Abe S, et al.High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection[J]. Gastric Cancer, 2016, 19(1): 198-205.
浙公网安备 33019902000101号 
